Silent information regulator 1 mediates hippocampal plasticity through presenilin1

Neuroscience

Volumn 179, Issue , 2011, Pages 32-40

  Torres, G ^a   Dileo, J N ^a   Hallas, B H ^a   Horowitz, J M ^b   Leheste, J R ^a  

^a NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

^b MEDAILLE COLLEGE   (United States)

Author keywords

Amyloid precursor protein; Neural stem cells; Presenilin1; Rat; Resveratrol; Sirtuin1

Indexed keywords

NUCLEAR PROTEIN; PRESENILIN 1; RESVERATROL; SILENT INFORMATION REGULATOR PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; EMBRYO; FOOD INTAKE; HIPPOCAMPUS; HUMAN; HUMAN CELL; MALE; NERVE CELL PLASTICITY; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANTIOXIDANTS; BLOTTING, WESTERN; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEK293 CELLS; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEURONAL PLASTICITY; PRESENILIN-1; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIRTUIN 1; STILBENES;

EID: 79952620546     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.01.036     Document Type: Article

References (39)

1. Almeida L., Vaz-da-Silva M., Falcão A., Soares E., Costa R., Loureiro A.I., Fernandes-Lopes C., Rocha J.F., Nunes T., Wright L., Soares-da-Silva P. Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. Mol Nutr Food Res 2009, 53:S7-S15.
2. Baur J.A. Biochemical effects of SIRT1 activators. Biochim Biophys Acta 2010, 1804:1626-1634.
3. Baur J.A. Resveratrol, sirtuins, and the promise of a DR mimetic. Mech Ageing Dev 2010, 131:261-269.
4. Baur J.A., Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006, 5:493-506.
5. Blander G., Guarente L. The Sir2 family of protein deacetylases. Annu Rev Biochem 2004, 73:417-435.
6. Boocock D.J., Faust G.E., Patel K.R., Schinas A.M., Brown V.A., Ducharme M.P., Booth T.D., Crowell J.A., Perloff M., Gescher A.J., Steward W.P., Brenner D.E. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev 2007, 16:1246-1252.
7. Cantó C., Auwerx J. PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol 2009, 20:98-105.
8. Costa R.M., Honjo T., Silva A.J. Learning and memory deficits in Notch mutant mice. Curr Biol 2003, 13:1348-1354.
9. Cottart C.H., Nivet-Antoine V., Laguillier-Morizot C., Beaudeux J.L. Resveratrol bioavailability and toxicity in humans. Mol Nutr Food Res 2010, 54:7-16.
10. Croucher M.J., Patel H., Walsh D.T., Moncaster J.A., Gentleman S.M., Fazal A., Jen L.S. Up-regulation of soluble amyloid precursor protein fragment secretion in the rat retina in vivo by metabotropic glutamate receptor stimulation. Neuroreport 2003, 14:2271-2274.
11. Crowell J.A., Korytko P.J., Morrissey R.L., Booth T.D., Levine B.S. Resveratrol-associated renal toxicity. Toxicol Sci 2004, 82:614-619.
12. De Strooper B. Loss-of-function presenilin mutations in Alzheimer's disease. Talking point on the role of presenilin mutations in Alzheimer's disease. EMBO Rep 2007, 8:141-146.
13. Donmez G., Wang D., Cohen D.E., Guarente L. SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell 2010, 142:320-332.
14. Feige J.N., Auwerx J. Transcriptional targets of sirtuins in the coordination of mammalian physiology. Curr Opin Cell Biol 2008, 20:303-309.
15. Gan L., Mucke L. Paths of convergence: sirtuins in aging and neurodegeneration. Neuron 2008, 58:10-14.
16. Handler M., Yang X., Shen J. Presenilin-1 regulates neuronal differentiation during neurogenesis. Development 2000, 127:2593-2606.
17. Ishibashi M., Ang S.L., Shiota K., Nakanishi S., Kageyama R., Guillemot F. Targeted disruption of mammalian hairy and Enhancer of split homolog-1 (HES1) leads to up-regulation of neural helix-loop-helix factors, premature neurogenesis, and severe neural tube defects. Genes Dev 1995, 9:3136-3148.
18. Ishibashi M., Moriyoshi K., Sasai Y., Shiota K., Nakanishi S., Kageyama R. Persistent expression of helix-loop-helix factor HES-1 prevents mammalian neural differentiation in the central nervous system. EMBO J 1994, 13:1799-1805.
19. Jankowsky J.L., Fadale D.J., Anderson J., Xu G.M., Gonzales V., Jenkins N.A., Copeland N.G., Lee M.K., Younkin L.H., Wagner S.L., Younkin S.G., Borchelt D.R. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 2004, 13:159-170.
20. Jarriault S., Brou C., Logeat F., Schroeter E.H., Kopan R., Israel A. Signalling downstream of activated mammalian Notch. Nature 1995, 377:355-358.
21. McClung C.A., Nestler E.J. Neuroplasticity mediated by altered gene expression. Neuropsychopharmacology 2008, 33:3-17.
22. Meng X., Maliakal P., Lu H., Lee M.J., Yang C.S. Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice. J Agric Food Chem 2004, 52:935-942.
23. Michán S., Li Y., Chou M.M., Parrella E., Ge H., Long J.M., Allard J.S., Lewis K., Miller M., Xu W., Mervis R.F., Chen J., Guerin K.I., Smith L.E., McBurney M.W., Sinclair D.A., Baudry M., de Cabo R., Longo V.D. SIRT1 is essential for normal cognitive function and synaptic plasticity. J Neurosci 2010, 30:9695-9707.
24. Michan S., Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J 2007, 404:1-13.
25. Mokni S., Elkahoui S., Limam F., Amri M., Aouani E. Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat. Neurochem Res 2007, 32:981-987.
26. Presente A., Andres A., Nye J.S. Requirement of Notch in adulthood for neurological function and longevity. Neuroreport 2001, 12:3321-3325.
27. Presente A., Boyles R.S., Serway C.N., de Belle J.S., Andres A.J. Notch is required for long-term memory in Drosophila. Proc Natl Acad Sci U S A 2004, 101:1764-1768.
28. Prozorovski T., Schulze-Topphoff U., Glumm R., Baumgart J., Schröter F., Ninnemann O., Siegert E., Bendix I., Brüstle O., Nitsch R., Zipp F., Aktas O. Sirt1 contributes critically to the redox-dependent fate of neural progenitors. Nat Cell Biol 2008, 10:385-394.
29. Ramadori G., Lee C.E., Bookout A.L., Lee S., Williams K.W., Anderson J., Elmquist J.K., Coppari R. Brain SIRT1: anatomical distribution and regulation by energy availability. J Neurosci 2008, 28:9989-9996.
30. Saura C.A., Choi S.Y., Beglopoulos V., Malkani S., Zhang D., Shankaranarayana Rao B.S., Chattarji S., Kelleher R.J., Kandel E.R., Duff K., Kirkwood A., Shen J. Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 2004, 42:23-36.
31. Soriano P., Montgomery C., Geske R., Bradley A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 1991, 64:693-702.
32. Steinberg G.R., Kemp B.E. AMPK in Health and Disease. Physiol Rev 2009, 89:1025-1078.
33. Torres G., Frisella P.D., Yousuf S.J., Sarwar S., Baldinger L., Zakhary S.M., Leheste J.R. A ChIP-cloning approach linking SIRT1 to transcriptional modification of DNA targets. Biotechniques 2008, 44:Pxii-Pxiv.
34. Torres G., Meeder B.A., Hallas B.H., Gross K.W., Horowitz J.M. Preliminary evidence for reduced social interactions in Chakragati mutants modeling certain symptoms of schizophrenia. Brain Res 2005, 1046:180-186.
35. Wang Q., Xu J., Rottinghaus G.E., Simonyi A., Lubahn D., Sun G.Y., Sun A.Y. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res 2002, 958:439-447.
36. Wang Y., Chan S.L., Miele L., Yao P.J., Mackes J., Ingram D.K., Mattson M.P., Furukawa K. Involvement of Notch signaling in hippocampal synaptic plasticity. Proc Natl Acad Sci U S A 2004, 101:9458-9462.
37. Wenzel E., Soldo T., Erbersdobler H., Somoza V. Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats. Mol Nutr Food Res 2005, 49:482-494.
38. Whitsett T., Carpenter M., Lamartiniere C.A. Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats. J Carcinog 2006, 5:15.
39. Zakhary S.M., Ayubcha D., Dileo J.N., Jose R., Leheste J.R., Horowitz J.M., Torres G. Distribution analysis of deacetylase SIRT1 in rodent and human nervous systems. Anat Rec (Hoboken) 2010, 293:1024-1032.